DrugPatentWatch Database Preview
Details for Patent: 10,039,757
Which drugs does patent 10,039,757 protect, and when does it expire?
Patent 10,039,757 protects CABOMETYX and is included in one NDA.
This patent has thirty-three patent family members in sixteen countries.
Summary for Patent: 10,039,757
| Title: | C-Met modulator pharmaceutical compositions |
| Abstract: | Pharmaceutical compositions and unit dosage forms comprising Compound I are disclosed. ##STR00001## |
| Inventor(s): | Wilson; Jo Ann (San Francisco, CA), Shah; Khalid (Half Moon Bay, CA) |
| Assignee: | Exelixis, Inc. (Alameda, CA) |
| Application Number: | 15/426,804 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,039,757
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | CABOMETYX | cabozantinib s-malate | TABLET;ORAL | 208692-001 | Apr 25, 2016 | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ADVANCED RENAL CELL CARCINOMA | Start Trial | ||||
| Exelixis Inc | CABOMETYX | cabozantinib s-malate | TABLET;ORAL | 208692-002 | Apr 25, 2016 | RX | Yes | No | Start Trial | Start Trial | TREATMENT OF ADVANCED RENAL CELL CARCINOMA | Start Trial | ||||
| Exelixis Inc | CABOMETYX | cabozantinib s-malate | TABLET;ORAL | 208692-003 | Apr 25, 2016 | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF ADVANCED RENAL CELL CARCINOMA | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,039,757
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 082252 | Start Trial | |||
| Australia | 2011278950 | Start Trial | |||
| Australia | 2016247044 | Start Trial | |||
| Australia | 2018220045 | Start Trial | |||
| Brazil | 112013000980 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
